Salix Coronary Plaque vs BodyGuardian Remote Monitoring System
AI Verdict
Choose Salix Coronary Plaque if…
Choose Salix Coronary Plaque if you need rapid, AI-driven analysis of CCTA scans to assess coronary artery plaque and stenosis at the point of care. This tool is ideal for quickly identifying high-risk plaque features and quantifying calcifications to aid in the diagnosis and risk stratification of coronary artery disease.
View Salix Coronary Plaque →Choose BodyGuardian Remote Monitoring System if…
Choose BodyGuardian Remote Monitoring System if you require continuous, long-term ambulatory monitoring for the detection and management of non-lethal cardiac arrhythmias. This wearable device is best suited for patients needing comprehensive physiological data collection (ECG, heart rate, respiration) over an extended period, leveraging AI for accurate rhythm analysis in a patient's daily life.
View BodyGuardian Remote Monitoring System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Salix Coronary Plaque | BodyGuardian Remote Monitoring System |
|---|---|---|
| Pricing | Subscription model | Unknown |
| Deployment | Cloud-based (Amazon Web Services), web-based software application | Cloud-based platform with EMR integration. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
BodyGuardian Remote Monitoring SystemTool B, the BodyGuardian Remote Monitoring System, offers a multi-faceted approach to usability by prioritizing patient comfort and ease of data transmission with its wearable design. It also provides flexible review options for clinicians via web and mobile applications. In contrast, Tool A, Salix Coronary Plaque, primarily focuses on clinician workflow integration for diagnostic interpretation from CCTA scans.
Clinical Value
Salix Coronary PlaqueBoth tools are FDA-cleared and address significant clinical needs. However, Salix Coronary Plaque (Tool A) provides a deeper diagnostic insight into coronary artery disease by not only detecting plaque and stenosis but also identifying specific high-risk plaque features from CCTA scans. This detailed characterization offers substantial value in risk stratification and guiding treatment decisions for a prevalent and critical condition.
Pricing & Value
Salix Coronary PlaqueSalix Coronary Plaque (Tool A) offers greater transparency by stating a per-scan assessment model and explicitly mentioning a US CPT reimbursement rate of US$950 per assessment. This provides a clear pathway for healthcare providers to understand the cost and potential revenue. BodyGuardian Remote Monitoring System (Tool B) does not publicly disclose its pricing, making it difficult to assess its value proposition without direct vendor contact.
Enterprise Readiness
BodyGuardian Remote Monitoring SystemBodyGuardian Remote Monitoring System (Tool B) explicitly states its HIPAA compliance and implies a Business Associate Agreement (BAA), which are crucial for handling Protected Health Information (PHI) in an enterprise healthcare setting. While Salix Coronary Plaque (Tool A) is generally expected to be HIPAA compliant, Tool B's explicit declarations provide greater assurance regarding data security and regulatory adherence for enterprise adoption.
Innovation
Salix Coronary PlaqueSalix Coronary Plaque (Tool A) demonstrates significant innovation by leveraging AI to provide highly detailed and specific characterization of coronary plaque, including the identification of multiple high-risk features like low-attenuation plaque, spotty calcification, positive remodeling, and napkin-ring sign from CCTA scans. This level of granular diagnostic insight pushes the boundaries of non-invasive CAD assessment.
Support & Docs
BodyGuardian Remote Monitoring SystemWhile specific details for support and documentation are not extensively provided for either tool in the initial facts, BodyGuardian Remote Monitoring System (Tool B) is a product of Preventice Technologies, now part of Boston Scientific Cardiac Diagnostics. Boston Scientific, as a large and established medical device company, provides comprehensive patient and healthcare professional support, including manuals, FAQs, and dedicated contact channels for its BodyGuardian monitors.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Salix Coronary Plaque | BodyGuardian Remote Monitoring System |
|---|---|---|
| Primary Function | Provides near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans, aiding in the rapid and accurate diagnosis of coronary artery disease. | Collects and transmits physiological data for the detection and monitoring of non-lethal cardiac arrhythmias in ambulatory patients. |
| Company | Artrya Limited | Preventice Technologies (now Boston Scientific Cardiac Diagnostics) |
| Primary Categories | Cardiology AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Key Clinical Focus | Coronary artery plaque and stenosis assessment, CAD diagnosis. | Detection and monitoring of non-lethal cardiac arrhythmias. |
| Specific AI Application | AI-enabled CCTA analysis for detection and quantification of coronary plaque, identification of high-risk plaque features, and stenosis assessment. | AI-powered analytics, including BeatLogic deep learning AI for accurate rhythm analysis. |
| Data Input/Source | CCTA scans | Wearable body sensor for continuous cardiac monitoring (ECG, heart rate, respiration rate, and activity level data). |
Videos
Demos, reviews, and walkthroughs featuring Salix Coronary Plaque and BodyGuardian Remote Monitoring System.